Carleton College

Carleton Digital Commons
Faculty Work

Psychology

2008

Biological Challenge Procedures Used to Study Co-occurring
Nicotine Dependence and Panic Disorder
Kenneth Abrams
Carleton College

Koen Schruers
Maastricht University, Netherlands

Fiammetta Cosci
Maastricht University, Netherlands

Shaun Sawtell
Carleton College

Follow this and additional works at: https://digitalcommons.carleton.edu/psyc_faculty
Part of the Psychology Commons

Recommended Citation
Abrams, K., Schruers, K., Cosci, F., & Sawtell, S. (2008). Biological Challenge Procedures Used to Study Cooccurring Nicotine Dependence and Panic Disorder. Addictive Behaviors, 33, 1463-1469. Available at:
https://doi.org/10.1016/j.addbeh.2008.02.018. Accessed via Faculty Work. Psychology. Carleton Digital
Commons. https://digitalcommons.carleton.edu/psyc_faculty/5
The definitive version is available at https://doi.org/10.1016/j.addbeh.2008.02.018

This Article is brought to you for free and open access by the Psychology at Carleton Digital Commons. It has been
accepted for inclusion in Faculty Work by an authorized administrator of Carleton Digital Commons. For more
information, please contact digitalcommons.group@carleton.edu.

Addictive Behaviors 33 (2008) 1463–1469

Contents lists available at ScienceDirect

Addictive Behaviors

Biological challenge procedures used to study co-occurring nicotine
dependence and panic disorder
Kenneth Abrams a,⁎, Koen Schruers b, Fiammetta Cosci b, Shaun Sawtell a
a
b

Carleton College, Northﬁeld, MN, United States
Maastricht University, Netherlands

a r t i c l e

i n f o

Keywords:
Nicotine dependence
Smoking
Panic disorder
Biological challenges
Comorbidity

a b s t r a c t
A wide array of biological challenge procedures – including carbon dioxide inhalation,
hyperventilation, and breath holding – have been used to model panic in laboratory settings.
Originally used to study developmental processes in panic disorder (PD), these procedures,
along with nicotine patch administration and self-administered smoking, have recently been
applied to help understand the etiology of co-occurring nicotine dependence and PD. The goals
of the present paper are to review studies that have employed biological challenges to study the
comorbid condition, identify the advantages and limitations of the various procedures, describe
desirable outcome measures for use in biological challenges, and present recommendations for
future challenge studies in this ﬁeld. We argue that biological challenges, though in need of
standardization, are useful for studying the development, maintenance, prevention, and
treatment of comorbid nicotine dependence and PD.
© 2008 Elsevier Ltd. All rights reserved.

Panic disorder (PD) and nicotine dependence are two disorders that readily lend themselves to laboratory manipulation. The
explicit, discrete symptoms of panic can reliably be produced through a number of biological challenge procedures. Nicotine can be
administered transdermally or by smoking, and recent smoking (or abstinence) can be biochemically veriﬁed with simple, inexpensive
tests. In fact, a wide array of biological challenge procedures – including carbon dioxide (CO2) inhalation, hyperventilation, breath
holding, and stimulant administration – have been used to model panic in laboratory settings. Originally used to study developmental
processes in PD, these procedures have more recently been applied to help understand the etiology of co-occurring nicotine
dependence and PD. The goals of the present paper are to review studies that have employed biological challenges to study the
comorbid condition, identify the advantages and limitations of the various procedures, describe desirable outcome measures for use in
biological challenges, and present recommendations for future challenge studies in this ﬁeld.
1. Respiratory challenge procedures
1.1. Carbon dioxide breathing challenges
Cohen and White (1950) were among the ﬁrst to explore the relation between CO2 and anxiety. They found that breathing a 4%
CO2 gas mixture for 12 min produced “anxiety attacks” among patients with “neurocirculatory asthenia” (akin to PD) though not
among healthy controls. Little was made of this discovery until the 1980s when Gorman et al. (1984) reported that voluntary
hyperventilation of a 5% CO2 gas mixture (though not of room air) led to anxiety among PD patients, and, independently, Greiz and
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Vandenhout (1984) noticed that a single 35% CO2 inhalation reliably produced anxiety in PD patients. Since then a number of other
groups have reported that CO2 inhalations induce uncomfortable somatic sensations (such as chest discomfort, dizziness, sweating,
and shortness of breath) and panic attacks more often in panic patients than among healthy controls (e.g., Woods, Charney,
Goodman, & Heninger, 1988). More commonly the balance of the gas mixture is pure oxygen (in part to avoid the confounding
effect of hypoxia; see Li et al., 2006) although recently there has been a trend for the balance to be room air.
To clarify some terms, hypercapnia refers to having a high bloodstream level of CO2. Respiratory acidosis occurs when
hypercapnia and low blood pH levels are achieved by inhaling high concentrations of CO2. Both breath holding challenges (discussed
later) and CO2 breathing challenges induce states of hypercapnia and respiratory acidosis. Interestingly, hyperventilation challenges
(also discussed later) induce fear in individuals vulnerable to panic but do so by producing states of hypocapnia (having a low
bloodstream level of CO2) and respiratory alkalosis (in which a high blood pH level is achieved). To some, these ﬁndings indicate that
the root cause of PD may be learned (fear) responses to unusual somatic sensations rather than hypercapnia per se (Barlow, 2002). A
recent, alternative explanation posits that both hypercapnia and hypocapnia ultimately cause changes in pH levels, and this may be
the common pathway in the similarity of their effects (Esquivel, Schruers, & Griez, 2008).
There are several reasons, though, why CO2 challenges have become the most widely used means to induce lab panic. The procedure
is easy to execute, non-invasive, and medically safe. Carbon dioxide readily crosses the blood-brain barrier, yet induced symptoms are
brief. Panic attacks experienced are similar to naturally occurring ones with respect to symptoms, duration, and severity (Perna et al.,
1994; Van den Hout, Van der Molen, Griez, Lousberg, & Nansen, 1987). Responses to the challenge within patients are consistent across
time (Perna et al., 1994), and hypersensitivity to CO2 exists in those with or at risk for PD, the ﬁrst-degree relatives of those with PD, and
individuals with one of a few other disorders (e.g., situational phobia, post-menstrual dysphoric disorder; Griez & Schruers, 1998).
Further, CO2 challenges allow for the assessment of cognitive factors as they impact panic vulnerability. For example, whether
participants are informed about the onset, duration, and potential symptoms/harmfulness of CO2 breathing (i.e., predictability
factors) can be experimentally manipulated (e.g., Abelson, Weg, Nesse, & Curtis, 1996). To assess the importance of control factors
in provoking panic, participants can be given offset control (Van den Bergh, Vandendriessche, de Broeck, & Van de Woestijne,
1993), a dial that adjusts the inhaled CO2 level (Abelson et al., 1996), or even a sham CO2 control dial (Sanderson, Rapee, & Barlow,
1989). Applied to co-occurring nicotine dependence, researchers could vary the instructional set to further our understanding of
how control, predictability, and expectancies affect panic vulnerability among smokers.
There are three primary techniques by which CO2 is delivered in lab settings:
Single- or Double-Breath Inhalation. With this technique, participants take one or two vital capacity (maximum volume) inhalations
of a 35% CO2 gas mixture through a mask covering the nose and mouth. Compared with other CO2 delivery techniques (described next),
this technique produces the highest systemic CO2 exposure (hypercapnia) but for the briefest duration. In fact the high CO2 levels very
rapidly produce hyperventilation and hence hypocapnia and respiratory alkalosis (Zandbergen, Pols, de Loof, Lousberg, & Greiz, 1989).
Because this technique is the simplest and quickest of the three, more participants can be run in a ﬁxed time period, premature
challenge termination rarely occurs, and there is a lower possibility of losing participants to machine malfunction.
Steady-State Breathing. With this technique participants continuously breathe a steady-state level (typically 5 or 7%) of CO2 for a
ﬁxed amount of time (e.g., 10 or 20 min) or until a panic attack occurs. The CO2 can be delivered with a respiratory canopy in which a
clear plastic hood is placed over the participant's head or though a gas mask with continuous positive air pressure that ﬁts over the
participant's nose and mouth. Of note, exit interviews have shown that the canopy itself leads some participants to feel “suffocated”
or “trapped” (Sanderson & Wetzler, 1990). This could be considered advantageous if the goal is to produce panic attacks or examine
the role of external danger cues; however, this could be considered disadvantageous if the aim is to isolate the speciﬁc anxiogenic
properties of CO2. With either delivery system, the participant experiences a state of hypercapnia and respiratory acidosis.
Rebreathing. With the Read rebreathing technique (named after its designer; Read, 1967), participants rebreathe (breathe in and
out of a closed system) a gas mixture that typically starts with 5–7% CO2 (e.g., Abrams et al., in press). The percentage of CO2 in the
system gradually increases as the individual continuously inhales from and exhales into the system through an oral mask, typically
reaching levels 2–3% higher within 5 min (e.g., Abrams et al., in press). Of note, whether the gas mixture is initially 5% or 7% has a
signiﬁcant impact on panic rates. For example, Gorman and colleagues found that an initially-5% CO2 gas mixture produced panic
attacks in 29% of PD patients and 6% of controls whereas an initially-7% CO2 gas mixture produced panic attacks in 68% of panic
patients and 12% of controls (Gorman et al., 1988).
Supplies needed for this technique include a non-diffusing gas bag and a mouth-breathing, nasal-occluding, non-rebreathing
(to ensure the gas circulates) face mask. Such a mask has little dead space, does not allow the participant to smell the gas mixture,
and precludes the need for an anxiety-provoking noseclip (Askanazi, Foster, Hyman, Milic-Emili, & Kinney, 1980). As with steadystate breathing, participants reach a state of hypercapnia and respiratory acidosis.
To allow the identiﬁcation of the speciﬁc effects of the gas mixture (vs. of environmental factors), participants can breathe room
air through the mask before the experimenter remotely changes the inhalation source to the gas bag (e.g., through the inﬂation and
deﬂation of balloon valves). With an advanced instrumentation module, respiratory measures, such as tidal volume, respiratory
rate, and end-tidal partial pressure of CO2 (etpCO2, a measure of the concentration of CO2 in exhaled air), can be assessed at ﬁxed
intervals and instantly downloaded onto a computer. Recording eptCO2, though not absolutely necessary, allows the experimenter
to check that the desired levels of CO2 were administered and to use etpCO2 values as a within-subject independent variable.
The primary advantage of the Read method is that participants are exposed to a wide range of CO2 levels in a single experimental
session and hence graphs showing changes in physiological, psychological, and behavioral parameters against changes in etpCO2 can
be constructed. A disadvantage of the technique is that, with increasing levels of CO2, early termination becomes more likely, which can
make comparisons of pre- to post-challenge change scores across participants challenging to interpret.
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Relevant Panic/Smoking Studies. At least two studies have utilized CO2 challenges in the investigation of panic and smoking. In
one, heavy smokers who were physically and psychologically healthy were divided into those who in the past were able to quit for
at least seven days (n = 10) and those who were unable to quit for that long (n = 12; Zvolensky, Feldner, Eifert, & Brown, 2001). All
were administered a steady-state 20% CO2 gas mixture for 25 s. Those unable to quit for long periods experienced heightened
cognitive and affective (though not physiological) reactivity to the challenge.
In a study employing the Read rebreathing method, Abrams et al. (in press) examined 24 heavy smokers in nicotine withdrawal
and 24 non-smokers on subjective and physiological reactivity to a 4-minute CO2 challenge. Results indicated that, despite
decreased respiration during the challenge, smokers experienced a signiﬁcantly greater increase in self-reported panic symptoms
than non-smokers. Such ﬁndings are consistent with the idea that smoking may promote fearful responding to somatic sensations
and hence may be a panic vulnerability factor.
1.2. Breath holding challenges
Breath holding, of course, is a simple procedure requiring no specialized equipment. The duration of maximal breath holding
had been thought to reﬂect tolerance to CO2 or physical sensations, with shorter times reﬂecting lower tolerance. However, given
that duration is highly inﬂuenced by initial arterial CO2 levels (which tend to be low in those who chronically hyperventilate, such
as panic patients), etpCO2 at the ﬁrst exhalation following maximal breath holding is now thought to better reﬂect tolerance to CO2.
For example, Rassovsky and colleagues found that, among PD patients, etpCO2 after maximal breath holding but not duration of the
breath holding predicted anxiety from a subsequent CO2 rebreathing challenge (Rassovsky, Kushner, Schwarze, & Wangensteen,
2000). This group later showed that panic patients had lower etpCO2 levels at maximal breath holding than healthy controls,
indicating a lower tolerance to CO2 (Rassovsky, Abrams, & Kushner, 2006).
It has been argued that, beyond assessing tolerance to CO2 and/or bodily sensations, breath holding challenges also assess
differences in stoicism and motivation. For example, in one study PD patients demonstrated the same breath holding duration as
those with mood disorders and a shorter duration than healthy controls, reﬂecting perhaps the relevance of motivation (Van der
Does, 1997). To eliminate the impact of stoicism and motivation, Roth and colleagues asked patients with PD, patients with
generalized anxiety disorder, and healthy controls to hold their breath for ﬁxed (standardized) durations (i.e., for 30 s 12 times,
separated by 60 s of normal breathing; Roth, Wilhelm, & Trabert, 1998). The three groups reacted quite similarly across a range
of affective and physiological measures. Because the panic group had lower baseline etpCO2 levels, the authors concluded that
breath holding for ﬁxed durations, while minimizing motivational factors, may not adequately test CO2 tolerance in those with
PD.
Relevant Panic/Smoking Studies. Brown and colleagues found that smokers' maximum breath holding duration positively
correlated with duration of past quit attempts (Brown, Lejuez, Kahler, & Strong, 2002), while Zvolensky and colleagues found no
relationship between these variables (Zvolensky et al., 2001).
1.3. Hyperventilation challenges
Hyperventilation involves breathing in excess of metabolic needs (Rassovsky, Hurliman, Abrams, & Kushner, 2004) and leads to
a state of hypocapnia and respiratory alkalosis (Nunn, 1987). When used as a biological challenge procedure, participants are
typically instructed to breathe every 2 s for durations ranging from 3 min (Zvolensky et al., 2004) to 15 min (Gorman et al., 1988).
Audiotaped instructions can be used to standardize the breathing tempo, and compliance can be examined through direct
observation or physiological measurement (Zvolensky et al., 2004).
Voluntary hyperventilation may result in dyspnea, dizziness, faintness, paresthesia, tachycardia, sweating, and feelings of
unreality (Hornsveld, Garssen, & van Spiegel, 1995). Although individuals with PD are more sensitive to hyperventilation challenges
than those with GAD or social phobia (Rapee, Brown, Antony, & Barlow, 1992), there is substantial evidence that hyperventilation is a
less potent anxiogen and panicogen than CO2 breathing (Papp et al., 1997; Zandbergen, Pols, de Loof, & Griez, 1991). In one study
voluntary hyperventilation produced panic attacks in 16% of PD patients while 66% of patients panicked in response to a 35% CO2
challenge (Goetz, Klein, Papp, Martinez, & Gorman, 2001). One proposed explanation for the milder impact of hyperventilation is
that it slowly results in respiratory alkalosis whereas CO2-breathing rapidly results in respiratory acidosis (Zandbergen et al., 1991).
Because of its milder effects, hyperventilation may be more useful as a method of testing fear proneness than panic proneness.
Additionally, because hyperventilation may be perceived as less aversive than CO2 challenges, participant recruitment may be
easier. Another advantage is the simplicity of the procedure.
Relevant Panic/Smoking Studies. At least two studies have utilized voluntary hyperventilation to study the relationship between
panic and smoking. In one, researchers found that, among psychologically healthy smokers, acute nicotine withdrawal symptoms
predicted anxiety reactivity to a three-minute hyperventilation challenge beyond other established predictors (negative affectivity,
anxiety sensitivity, and nicotine dependence; Zvolensky et al., 2005). This study demonstrated that greater levels of nicotine
withdrawal lead to greater perceived intensity of panic-relevant physical symptoms.
In another study, smokers with PD, smokers without PD, and non-smokers with PD engaged in a hyperventilation challenge
(Zvolensky et al., 2004). Smokers with PD experienced greater increases in anxiety and bodily distress at post-challenge and
recovery than the other two groups. There were no signiﬁcant differences in autonomic responding to the challenge among the
three groups. The authors concluded that hyperventilation promotes anxiety among smokers not through the production of more
autonomic sensations but rather through cognitive and affective channels.
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2. Pharmacologic challenge procedures
2.1. Nicotine patch challenges
Being administered transdermal nicotine results in slower absorption than smoking tobacco. In placebo-controlled challenge
studies, one advantage of using patches over cigarettes is that it is easier initially to keep participants blind to condition. On the
other hand, patches may cause nausea and vomiting in nicotine-naïve individuals resulting in premature patch removal (Cosci,
Abrams, Schruers, Rickelt, & Griez, 2006).
Relevant Panic/Smoking Studies. In one study researchers examined whether nicotine promotes heightened reactivity to a CO2
challenge in healthy non-smokers. The 35 participants underwent a single-breath 35% CO2 challenge after the administration of a
10-mg nicotine patch on one test day and of a placebo patch on another test day (Cosci et al., 2006). Results indicated that nicotine,
relative to the placebo, led to greater pre-challenge sympathetic activation (increases in blood pressure, heart rate, and physiological panic symptoms) though not pre-challenge subjective anxiety. Nicotine did not affect physiological or psychological
reactivity to the CO2 challenge itself. Future studies could repeat the protocol with more psychologically-vulnerable individuals
(e.g., non-smokers with high anxiety sensitivity, high suffocation fear, or PD) to examine whether nicotine promotes CO2
hypersensitivity in particular subgroups.
Another study examined, among 52 undergraduate smokers, the role of nicotine in attenuating anxiety and urge to smoke in
response to imagined anxiety and smoking cues (Morissette, Palfai, Gulliver, Spiegel, & Barlow, 2005). Participants were administered a
21-mg nicotine or placebo patch and then deprived of smoking for 4 h. Not surprisingly, participants reported a greater urge to smoke
during the absorption period when administered a nicotine (vs. placebo) patch. However, nicotine did not attenuate anxiety during the
absorption period nor did it attenuate anxiety or urge to smoke in response to imagined cues. Thus, the study ﬁndings were
inconsistent with the hypothesis that smokers in withdrawal are hypersensitive to anxiety- and smoking-relevant cues.
2.2. Smoking challenges
Recently-developed technology has enabled the measurement of various aspects of smoking topography. Cigarettes can be
mounted onto mouthpieces containing pressure transducers, and pressure changes caused by inhalation permit the recording of puff
volume, duration, and inter-puff interval (Breland, Evans, Buchhalter, & Eissenberg, 2002). As some evidence exists that anxiety
inﬂuences smoking topography (Pomerleau & Pomerleau, 1987), this technology remains ripe for future research on smoking and
panic. For example, to examine the extent to which somatic sensations promote and maintain smoking, smokers with PD and smokers
without PD could undergo a placebo-controlled CO2 challenge followed by a self-administered smoking period. More smoking in
response to the CO2 (vs. placebo) challenge would suggest that uncomfortable bodily sensations do promote or maintain smoking
behavior.
3. Measures
When studying lab panic, it is desirable to utilize physiological, subjective, and behavioral measures of anxiety. Additionally, the
judicious use of baseline variables (as potential moderator variables) can often assist with data interpretation.
3.1. Outcome measures
3.1.1. Physiological
The primary physiological measures used in studies of lab panic are respiratory. Minute ventilation is the product of respiratory
rate and tidal volume. All three variables can be plotted against time or, to control for differences in CO2 exposure, etpCO2. Some
researchers have found that changes in respiratory rate predict lab panic better than changes in tidal volume (e.g., Papp et al., 1997).
Additionally, high breathing variability and low baseline pCO2 (reﬂecting chronic hyperventilation) have been found to be potent
predictors of panic (Papp et al., 1997). The Approximate Entropy Index, a nonlinear measure of breathing irregularity and useful
outcome measure, was developed based on this knowledge (e.g., Caldirola, Bellodi, Cammino, & Perna, 2004). Smokers and PD
patients show higher entropy in baseline respiratory patterns than healthy non-smokers.
Salivary cortisol, which is elevated during spontaneously occurring panic attacks (Bandelow et al., 2000), is sometimes used as a
proxy for HPA activity. Smoking itself leads to a surge in cortisol activity (Kirschbaum and Strasburger, 1992), while acute
withdrawal leads to a drop (Broocks et al., 2002). As such, it may be desirable for researchers who are not speciﬁcally studying the
impact of withdrawal to have smoking participants smoke prior to challenge sessions in a controlled manner to minimize
confounded data.
Skin conductance has been infrequently measured in panic challenge paradigms. To date, the evidence that this variable reliably
correlates with panic vulnerability factors is mixed. For example, studies have variously found that skin conductance does not
distinguish between those with PD, those with generalized anxiety disorder, and healthy controls during a breath holding challenge
(Roth et al., 1998) but does distinguish those with PD from those with social phobia and healthy controls during a hyperventilation
challenge (Wilhelm, Gerlach, & Roth, 2001). Heart rate is often studied as an outcome measure in panic studies. However, when
using smokers in withdrawal in lab challenges, changes in heart rate are unlikely to parallel other measures of fear because nicotine
withdrawal results in dampened heart rate (Hughes, Higgins, & Hatsukami, 1990).
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3.1.2. Subjective
Symptom checklists, such as the Acute Panic Inventory (Gorman et al., 1984), are often used post-challenge to assess
participants' subjective experience of anxiety and panic (e.g., Rassovsky et al., 2004). To continuously assess subjective breathlessness levels during lab challenges, researchers have utilized dials (e.g., ranging from “no breathlessness” to “maximal breathlessness”; Rassovsky et al., 2004) and computerized Borg-type scales (e.g., ranging from “no air hunger” to “intolerable air hunger”;
Li et al., 2006). Questions have been raised, though, about the reliability and validity of self-report data on internal states during
challenges. It has been hypothesized that scores may be inﬂuenced by education, intelligence, emotional insightfulness, panic
history, and demand characteristics (Rassovsky & Kushner, 2003).
3.1.3. Behavioral
One behavioral measure of anxiety sometimes employed in lab studies is premature termination of the challenge itself.
However, while premature termination should be recorded, it may be inﬂuenced by motivational factors and hence may not be
a valid measure of anxiety (Ehlers, Margraf, & Roth, 1987). Other potential behavioral measures include the use of videotaping
or motion sensors to detect participant movement or avoidance-type behaviors (e.g., eye contact with the CO2 delivery
apparatus). Alternatively, if participants are permitted to smoke either in anticipation of or following a panic challenge,
several measures of smoking topography, including puff volume, duration, and inter-puff interval, can be electronically
recorded.
3.1.4. Panic
The lack of standardization for deﬁning lab panic has impaired comparison of panic rates across labs. Strict DSM-IV criteria (i.e.,
intense fear plus at least four other symptoms) may be overly inclusive in lab settings because most individuals exposed to CO2
challenges experience discomfort and a number of physiological symptoms (Sanderson & Wetzler, 1990). As such, some researchers
have required the presence of at least one cognitive symptom (e.g., the fear of losing control or going crazy) to establish lab panic
(e.g., Gorman et al., 1988). Such a requirement can be justiﬁed as the vast majority of individuals with PD report cognitive symptoms
during naturally occurring attacks (Barlow et al., 1985). Others have required an experimentally-observed “clear and sudden
increase” in anxiety (Gorman et al., 1994) or an acknowledgment that the induced panic attack was “very similar or identical” to
spontaneously occurring ones (Bradwejn & Koszycki, 1991). Barlow, Brown, and Craske (1994) proposed what is perhaps the most
comprehensive set of requirements for lab panic: intense fear, terror, or discomfort; a crescendo of symptoms within 5 min; a
measurable autonomic surge; and an urge to escape. Despite the comprehensiveness of this deﬁnition, it has not been widely
employed in other labs. Finally, the issue of whether lab panic should be considered a categorical or dimensional construct has been
raised (Rassovsky & Kushner, 2003).
3.2. Moderator variables
A number of individual difference variables have been found to or theorized to affect sensitivity to biological challenges.
Including measures of them for use as potential moderator variables during data analysis is recommended. These variables can be
roughly divided into the categories of smoking-related and anxiety-related.
3.2.1. Smoking-related variables
Rapidly lapsing after quitting smoking and having poor perceived health (e.g., as a result of smoking) are both associated with
heightened anxiety in response to bodily sensations (Zvolensky et al., 2001). Additionally, level of nicotine dependence (measured
by cigarettes smoked per day or a standardized dependence questionnaire such as the Fagerstrom Test of Nicotine Dependence;
Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991) has been hypothesized to correlate with sensitivity to challenge tests (Abrams
et al., in press). Smoking expectancies (e.g., sedation) and nicotine withdrawal expectancies (e.g., loss of control) may also affect
sensitivity (Zvolensky et al., 2005), although these hypotheses await further testing.
3.2.2. Anxiety-related variables
Two anxiety-related characteristics are associated with hypersensitivity to biological challenges. Anxiety sensitivity, typically
measured by the Anxiety Sensitivity Index (Reiss, Peterson, Gursky, & McNally, 1986), is the tendency to catastrophically interpret
somatic manifestations of stress and anxiety. Suffocation fear, typically measured by the Suffocation Fear Scale (Rachman & Taylor,
1994), is the tendency to interpret benign changes in air quality and quantity as signaling impending suffocation. Elevated levels of
anxiety sensitivity and suffocation fear predict heightened reactivity to CO2 challenges in PD patients (Rassovsky et al., 2000).
Additionally, among smokers, high anxiety sensitivity predicts early lapsing during quit attempts (Brown, Kahler, Zvolensky,
Lejuez, & Ramsey, 2001). An argument has been made that trait anxiety or neuroticism should be measured in addition to anxiety
sensitivity and suffocation fear to gauge whether higher-order or lower-order dimensions of negative affectivity confer the greater
risk for CO2 sensitivity (Zvolensky et al., 2001).
4. Future directions
Biological challenge procedures have the potential to shed light on etiologic and maintenance factors of the comorbid condition
as well as on the efﬁcacy of prevention and treatment approaches.
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4.1. Etiology and maintenance
While smokers in withdrawal are more sensitive to bodily sensations and hence at greater risk for experiencing panic attacks
than non-smokers (Abrams et al., in press), the mechanism(s) linking smoking to panic (e.g., chronic nicotine use, acute
withdrawal, etc) needs to be further explicated. Toward this end, smokers in various stages of smoking and withdrawal (e.g., no
withdrawal, acute withdrawal, prolonged abstinence) could be compared on CO2 sensitivity. Additionally, nicotine and placebo
patch groups could be included to help differentiate the psychological and pharmacologic effects of nicotine on CO2 sensitivity. To
examine maintenance (vs. etiologic) factors of the comorbid condition, these challenge studies could include smokers with PD and
non-smokers with PD (Zvolensky et al., 2005).
4.2. Prevention and treatment
One model for a prevention study would be to provide standard smoking cessation to a group of panic-free smokers, while
keeping others on a wait list, and examine between-group differences on CO2 sensitivity as a measure of panic vulnerability.
Treatment studies could involve the provision of cognitive, behavioral, and/or pharmacologic therapies to smokers with PD with
short-term outcome measures including sensitivity to and the extent of smoking following a biological challenge. If a treatment
were found to be successful, component analysis could be helpful for identifying the critical features of treatment. Preliminary
studies suggest that exposure to somatic sensations associated with panic and with smoking withdrawal could be beneﬁcial
(Zvolensky et al., 2005). A longstanding and still unresolved issue is whether the two conditions should be treated serially, in
parallel, or in an integrated fashion (Zvolensky, Schmidt, & Stewart, 2003).
4.3. Challenge methodology
Future research could also aim to improve the external validity of the challenge procedures themselves. Studies could compare
the utility of various challenge paradigms including, for CO2 studies, the dose of CO2, length of the challenge, and whether breathing
occurs in an open or closed system. Researchers could also examine the utility of various outcome measures (described earlier).
5. Conclusion
Respiratory and pharmacologic challenge procedures offer great potential for illuminating factors that cause and maintain the
co-occurrence of PD and smoking. Judicious use of dependent and moderator variables is necessary to maximize a given study's
potential. Greater standardization of equipment, protocol, and measures, including the deﬁnition of lab panic, would allow the
comparison of ﬁndings across laboratories to be made with greater ease.
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